QIAGEN Website    Quick Order    Online Seminar    Contact    My Account
Bookmark and Share Home  >  Resources  >  Online Seminars

For the most updated product information, visit GeneGlobe on QIAGEN website

Online Seminars

SABiosciences is pleased to provide free, on-line educational resources covering relevant tools and techniques for gene and protein expression analysis, and cell-based gene function analysis. We offer live webinars, prerecorded and PDF formatted presentations.

See the instructions for the Web Seminars

September 2016
Monday
Tuesday
Wednesday
Thursday
Friday

1

Digital NGS introduction

2

5

6

Controls and novel solutions for real-time qPCR

Analyzing fusion genes with NGS

7

Sample QC – quality samples for quality results

8

cfDNA handling and purification

Digital DNA-seq for cancer research

9

CTC detection and characterization

12

Cancer research and challenges of FFPE

13

Introduction to NGS

14

RNA sample QC

QPCR Introduction

15

QIAsymphony

Single cell technology introduction

16

19

Introduction to microRNA

20

Innovative NGS Library Construction Technology

21

NGS sample QC

Nucleic acid isolation from PCR inhibitor-rich sample types

22

Analysis of circulating cell-free DNA with NGS

Analyzing heterogeneous tumor samples

23

26

Onestep ahead RT-PCR

27

Advanced NGS library prep for challenging samples

28

FFPE sample QC

Tools for microbial detection and host-response analysis

29

cfDNA analysis and interpretation

30

Current Seminar Titles Available:

Focus Title
1.  Onestep ahead RT-PCROne step ahead for your RT-PCR
2.  RNAseq technologyDigital RNASeq: Technology introduction
3.  RNAseq technologyDigital RNAseq for gene expression profiling: Workflow and applications
4.  RNAseq technologyMolecular insight into gene expression using Digital RNAseq: Data analysis tutorial
5.  QuantiNova PCR kit The importance of controls and novel solutions for successful real-time qPCR
6.  Liquid BiopsiesNew Technology and workflow for integrated collection, stabilization, and purification of circulating cell-free DNA
7.  Liquid BiopsiesAnalysis and interpretation of cell free DNA
8.  Liquid BiopsiesLiquid biopsy: overcome challenges of circulating DNA with automated and standardized extraction processes
9.  Next-generation sequencingNew and highly integrated tools for sensitive next-generation sequencing: Analysis of circulating cell-free DNA
10.  QIAseq RNAScanAnalyzing fusion genes with next-generation sequencing technology
11.  Sample Quality ControlKeep control over the quality and reproducibility of your research by standardizing your nucleic acid samples
12.  Sample Quality ControlRNA Quality Control for results you can rely on - Interpret your gene-expression results with confidence
13.  Sample Quality ControlMaximize the success of your NGS experiments with state-of-the-art NGS library quality control solutions
14.  Sample Quality ControlNucleic acids quantification from FFPE samples; are you doing it right?
15.  QIAseq Targeted DNA PanelsDigital DNA-seq Technology - Targeted Enrichment for Cancer Research
16.  Sample PrepCancer Research and the Challenges of FFPE Samples
17.  QIAseq Library PrepIntroduction to Next Generation Sequencing (NGS) technology
18.  QIAseq Library PrepInnovative NGS Library Construction Technology
19.  QIAseq Library PrepAdvanced NGS library prep for challenging samples
20.  miScript miRNA ArraysIntroduction to microRNA
21.  Microbial DNA PCR ArraysStudying the microbiome: tools for microbial detection and host-response analysis
22.  AdnaTestsCTC Detection and molecular characterisation – Challenges and Solutions
23.  QIAGEN ServiceRNA-seq for biomarker discovery
24.  Stool sample prepMinimize biases in comparing metagenomics with metatranscriptomics: parallel isolation of DNA and RNA from stool sample

One step ahead for your RT-PCR

"At the heart of every successful discovery lie the seeds of innovation. At QIAGEN, we are constantly developing new methods that allow researchers to gain forward momentum with their research. Whether you’re studying gene expression or performing viral RNA analysis, the success of your experiment depends on the ability to analyze your sample with the highest standards of sensitivity and specificity so that you can have confidence in your data. To help you generate valuable insights from gene expression profiling and viral RNA analysis, we introduce the brand new QIAGEN OneStep Ahead RT-PCR Kit – the first hot-start reverse transcriptase kit on the market. Continuing the success story of its first- generation predecessor (QIAGEN OneStep RT-PCR Kit), the QIAGEN OneStep Ahead RT-PCR Kit is equipped with compelling new features that afford maximum convenience and ease of use, while delivering unmatched sensitivity and specificity. With a total reaction time of 1 hour, higher sequence accuracy and the ability to amplify amplicons of up to 4 kb without tedious optimization, you can get one step closer to publishing your findings with this new solution. For increased convenience, the kit comes in an all-in-one tube format along with a built-in pipetting control. Stay one step ahead of your peers and make significant advances in your research with the QIAGEN OneStep Ahead RT-PCR Kit! In this webinar we will introduce the new kit in detail and discuss its features and benefits. "

Duration: 45 minutes followed by Q&A session.

Schedule:

Tuesday, October 25, 2016 at 1:00 PM Eastern    Status: Available Reserve

Digital RNASeq: Technology introduction

QIAseq RNA is a revolutionary turnkey solution for digital gene expression analysis by NGS. From 10 genes to 1000, from one sample to 100, QIAseq RNA delivers precise results on both ION and Illumina sequencing platforms. The data from QIAseq RNA is directly comparable to expression analysis derived from whole transcriptome sequencing or by qRTPCR, only better, cheaper, faster and more flexible. This webinar will describe the principles of digital expression analysis by NGS, and review the features and benefits of the QIAseq system, options available and the integrated data analysis package.

Duration: 45 minutes followed by Q&A session.

Schedule:

Thursday, October 6, 2016 at 9:30 AM Eastern    Status: Available Reserve

Digital RNAseq for gene expression profiling: Workflow and applications

Traditional RNA sequencing (RNA-Seq) is a powerful tool for expression profiling, but is hindered by PCR amplification bias and inaccuracy at low expressing genes. QIAseq RNA is a flexible and precise tool developed for mitigating these complications, allowing digital gene expression analysis. This in-depth webinar will cover sample requirements, experimental design, NGS platform-specific challenges and workflow for gene enrichment, library prep and sequencing. The applications of QIASeq RNA Panels in cancer research, stem cell differentiation and elucidating the effects small molecules on signaling pathways will be highlighted.

Duration: 45 minutes followed by Q&A session.

Schedule:

Thursday, October 13, 2016 at 9:30 AM Eastern    Status: Available Reserve

Molecular insight into gene expression using Digital RNAseq: Data analysis tutorial

Gene expression profiling is the key to understanding biological pathways and complex cellular systems. In this webinar, we will discuss the challenges of targeted RNA-seq data analysis and present the solutions provided by the QIAGEN automated online data analysis tools. Using raw sequencing data from targeted sequencing, the output of the QIAseq primary data analysis tool and the options in QIAseq secondary analysis, such as normalization strategies, will be described. The use of Ingenuity Pathway Analysis (IPA) to unlock the molecular insights buried in experimental data by quickly identifying relationships, mechanisms, functions, and pathways of relevance will be shown with an example.

Duration: 45 minutes followed by Q&A session.

Schedule:

Thursday, October 27, 2016 at 9:30 AM Eastern    Status: Available Reserve

The importance of controls and novel solutions for successful real-time qPCR

"The increasing demand for streamlined, monitored, and ultrafast qPCR procedures requires high-performance, real-time quantitative RT and PCR chemistries. Particularly procedures utilizing generic kits for gene expression analysis should include in-process safety measures to avoid variables and control accuracy of procedures and results. This webinar presents innovative solutions for one-step and two-step RT-PCR that significantly enhance performance and reliability in qRT-PCR. The new QuantiNova kit family offers a combination of various integrated safety features to remove variables and prevent artifacts. Internal Control RNA, removal of genomic DNA, room temperature set up capability for RT-PCR, and a built-in visual pipetting control verify accurate procedures, ensuring reliable gene expression profiling. This webinar explains the principles of the technologies and shows data demonstrating performance in qRT-PCR. Find out how you can verify accurate performance in qRT-PCR and improve your results."

Duration: 45 minutes followed by Q&A session.

Schedule:

Tuesday, October 4, 2016 at 1:00 PM Eastern    Status: Available Reserve

New Technology and workflow for integrated collection, stabilization, and purification of circulating cell-free DNA

Research into non-invasive prenatal testing (NIPT) and circulating tumor DNA (ctDNA) testing based on circulating cell-free DNA (ccfDNA) is rapidly expanding. However, detection and quantification of ccfDNA is compromised by the release of genomic DNA (gDNA) from lymphocytes due to mechanical lysis or apoptosis during blood collection, storage and transport. PreAnalytiX has developed the PAXgene® Blood ccfDNA System, consisting of the PAXgene Blood ccfDNA Tube, a plastic blood collection tube with a unique, non-crosslinking chemistry that preserves extracellular levels of ccfDNA and prevents the release of intracellular DNA from cells into the plasma, and the QIAsymphony® PAXgene Blood ccfDNA Kit for automated ccfDNA extraction from up to 5 ml of plasma. In this webinar, this new technology development will be presented in comparison to other existing technologies.

Duration: 45 minutes followed by Q&A session.

Schedule:

Thursday, October 6, 2016 at 1:00 PM Eastern    Status: Available Reserve

Analysis and interpretation of cell free DNA

Identification and monitoring of cancer mutations from cell free DNA-Seq data is a key application in liquid biopsy. In this part of the webinar we will show how mutations can be best identified from this type of data and how they can be interpreted. Furthermore, potential challenges when analyzing this type of data will be discussed together with relevant strategies.

Duration: 45 minutes followed by Q&A session.

Schedule:

Thursday, September 29, 2016 at 9:30 AM Eastern    Status: Available Reserve
Thursday, October 27, 2016 at 1:00 PM Eastern    Status: Available Reserve

Liquid biopsy: overcome challenges of circulating DNA with automated and standardized extraction processes

"Circulating, cell-free DNA (cfDNA) originating from malignant tumors, a developing fetus and also from inflammatory tissues, is present in the cell-free nucleic acids in plasma, serum and other body fluids and is considered a “liquid biopsy”. Access to cfDNA for analysis allows for specific detection of certain disease states based on a simple blood sample. Circulating cell-free DNA shows distinctive properties – it is present mostly as shorter fragments of less than 500 bp and the concentration of cfDNA in a plasma or serum sample is low (approximately 1–100 ng/ml) compared to cellular materials and varies considerably between different individuals. Because of their fragmented nature and low concentration, cfDNA presents a particular challenge for efficient extraction / purification and quantification, such as by qPCR. We present data on solutions for the following critical problems concerning the purification of cfDNA for research and molecular diagnostic applications: • Pre-analytical workflow (blood processing) for analyzing cfDNA • Optimization of cfDNA extraction from plasma samples: low target concentrations require efficient cfDNA enrichment from larger sample volumes • Novel automated extraction of cfDNA using the QIAsymphony SP instrument for liquid biopsy diagnostic applications "

Duration: 45 minutes followed by Q&A session.

Schedule:

Thursday, October 13, 2016 at 1:00 PM Eastern    Status: Available Reserve

New and highly integrated tools for sensitive next-generation sequencing: Analysis of circulating cell-free DNA

"Next-generation sequencing of free circulating DNA from plasma, serum and urine has been quickly adopted for cancer testing as well as for noninvasive prenatal testing (NIPT). For cancer patients, this method enables noninvasive diagnoses of actionable mutants to personalize anti-tumor therapies. In addition, this approach could be used to monitor molecular changes during cancer treatment or tumor progression. The concentration of free circulating DNA in liquid biopsies is usually very low. This highlights the critical need to use optimized protocols for cfDNA extraction to construct NGS DNA libraries. In this webinar, we will introduce new technical solutions for Ion Torrent as well as Illumina sequencing platforms that combine optimized cfDNA isolation, highly advanced library construction, unbiased library amplification and integrated data analysis to reliably analyze cfDNA samples with high sensitivity. "

Duration: 45 minutes followed by Q&A session.

Schedule:

Wednesday, October 5, 2016 at 11:00 AM Eastern    Status: Available Reserve
Thursday, October 20, 2016 at 1:00 PM Eastern    Status: Available Reserve

Analyzing fusion genes with next-generation sequencing technology

"Fusion genes are hybrid genes formed by the fusion of two separate genes. Translocation, interstitial deletion and chromosomal inversions are some of the genetic events that can lead to the formation of fusion genes. The occurrence of fusion genes and its implications in cancer have already been known, but the emergence of NGS technology – especially RNA sequencing – offers the potential to detect novel gene fusions. You can learn more about fusion genes and applying NGS to detect them at our upcoming webinar, presented by Raed Samara, Ph.D., QIAGEN’s Global Product Manager for NGS technologies. This webinar will cover: 1. Fusion genes: what they are and a historical perspective 2. Fusion gene detection: the current status 3. RNA sequencing vs. digital RNA sequencing 4. How to detect and accurately quantify novel fusion genes in your sample ? "

Duration: 45 minutes followed by Q&A session.

Schedule:

Tuesday, October 4, 2016 at 11:00 AM Eastern    Status: Available Reserve
Thursday, October 20, 2016 at 9:30 AM Eastern    Status: Available Reserve

Keep control over the quality and reproducibility of your research by standardizing your nucleic acid samples

"From starting material to final results, every analysis workflow is a journey to unlock the biological information within your samples without altering it, and quality results are only achieved from quality samples. Within each step lie challenges directly related to the sample type and analysis technologies, and at each step, there is potential for many things to go wrong, jeopardizing your experiments, results and reputation. Therefore, standardizing samples and performing relevant quality control after critical steps is of utmost importance to ensure quality and reproducibility of results as well as reliable interpretation. In this webinar, we will introduce you to the main sample quality parameters, their respective impact on downstream applications, how to monitor them and what are the advantages automating quality control along complex workflows."

Duration: 45 minutes followed by Q&A session.

Schedule:

Wednesday, October 5, 2016 at 1:00 PM Eastern    Status: Available Reserve

RNA Quality Control for results you can rely on - Interpret your gene-expression results with confidence

"By their very nature RNA molecules, especially mRNA and regulator RNA, are labile and can be highly unstable and sensitive to heat, UV and RNase contamination. The quality, relevance and scientific impact of gene-expression results directly depends on one’s ability to extract RNA without losing any fraction of interest while preserving the integrity of the biological information it carries. RNA quality control is thus critical to ensure quality results and turning these results into actionable insights with confidence. In this webinar, we will introduce you to the main parameters influencing RNA-based assays, their respective impact on downstream applications, how to monitor them and the advantages of automation for quality control along complex workflows."

Duration: 45 minutes followed by Q&A session.

Schedule:

Wednesday, October 12, 2016 at 1:00 PM Eastern    Status: Available Reserve

Maximize the success of your NGS experiments with state-of-the-art NGS library quality control solutions

"Next generation sequencing workflows are long and complex, multistep procedures to prepare NGS libraries of specific quality in term of molarity, purity and size distribution. The quality of the NGS library is the factor with the most influence on the success of the sequencing run, affecting both the sequence validity and the number of reads. Quality control procedures tracking success of library preparation steps ensure that only samples of good quality are processed into the resources-intensive sequencing runs, because discovering a problem with your libraries when interpreting data is synonym to significant waste of time, resources and of your precious template. In this webinar, we will introduce QC procedures for automated, objective and reliable NGS library quality control in order to bring your NGS QC to a new level of convenience and throughput. "

Duration: 45 minutes followed by Q&A session.

Schedule:

Wednesday, October 19, 2016 at 1:00 PM Eastern    Status: Available Reserve

Nucleic acids quantification from FFPE samples; are you doing it right?

"Formalin-fixation and paraffin-embedding is a standard method for long-term preservation of tissue biopsies and these stored samples are a valuable tool for studying diseases such as cancer, especially when they are histologically and pathologically well characterized, and follow-up clinical data is available. The quality of nucleic acids extracted from FFPE samples is influenced by a number of factors, including how the samples were handled before, during and after fixation & embedding. Moreover, there are several difficulties when purifying nucleic acids from FFPE samples as the chemicals & temperature used during the process can degrade the DNA. In this webinar we will discuss the variability in quantity and purity of DNA purified from FFPE material. We will show data from different quantification and quality control methods and demonstrate the impact of inaccurate quantification on downstream results and how to overcome these challenges. "

Duration: 45 minutes followed by Q&A session.

Schedule:

Wednesday, September 28, 2016 at 9:30 AM Eastern    Status: Available Reserve
Wednesday, October 26, 2016 at 1:00 PM Eastern    Status: Available Reserve

Digital DNA-seq Technology - Targeted Enrichment for Cancer Research

Targeted DNA sequencing has become a powerful approach by achieving high coverage of the region of interest while keeping the cost of sequencing and complexity of data interpretation manageable. However, existing PCR-based target enrichment approaches introduce errors due to PCR amplification bias and artifacts, which significantly affects quantification accuracy and limit the ability to confidently detect low-frequency DNA variants. This webinar introduces a new digital sequencing approach that is based on the use of unique molecular indices (UMIs) - QIAseq Targeted DNA Panels. With UMIs, each unique DNA molecule is barcoded before any amplification takes place to correct for PCR errors. Detailed workflow and applications in cancer research will be presented. Join us and learn about this exciting novel digital DNAseq technology.

Duration: 45 minutes followed by Q&A session.

Schedule:

Monday, October 3, 2016 at 11:00 AM Eastern    Status: Available Reserve

Cancer Research and the Challenges of FFPE Samples

Duration: 45 minutes followed by Q&A session.

Schedule:

Monday, October 10, 2016 at 1:00 PM Eastern    Status: Available Reserve

Introduction to Next Generation Sequencing (NGS) technology

"Next-generation sequencing (NGS) is a driving force for numerous new and exciting applications, including cancer research, stem cell research, metagenomics, population genetics, medical research and single cell analysis. While NGS technology is continuously improving, library preparation remains one of the biggest bottlenecks in the NGS workflow and includes several time-consuming steps that can result in considerable sample loss and the potential to introduce handling errors. Moreover conducting single-cell genomic analysis using NGS methods has traditionally been challenging since the amount of genomic DNA present in a single cell is very limited. In this webinar we will discuss methods for the preparation of high-quality DNA libraries for use on Illumina NGS platforms using a novel streamlined one-step enzymatic fragmentation, end-repair and A-addition protocol. We will discuss complete PCR-free solutions for whole genome and whole transcriptome sequencing from isolated single cells and low amounts of genomic DNA or RNA combined with a time-saving, one-tube library preparation protocol that does not require extra nucleic acids fragmentation and sample cleanup between steps, minimizing starting material loss and cross-contamination risk, thereby increasing the resolution of NGS data."

Duration: 45 minutes followed by Q&A session.

Schedule:

Monday, October 17, 2016 at 1:00 PM Eastern    Status: Available Reserve

Innovative NGS Library Construction Technology

"Next-generation sequencing (NGS) is a driving force for numerous new and exciting applications, including cancer research, stem cell research, metagenomics, population genetics, medical research and single cell analysis. While NGS technology is continuously improving, library preparation remains one of the biggest bottlenecks in the NGS workflow and includes several time-consuming steps that can result in considerable sample loss and the potential to introduce handling errors. Moreover conducting single-cell genomic analysis using NGS methods has traditionally been challenging since the amount of genomic DNA present in a single cell is very limited. In this webinar we will discuss methods for the preparation of high-quality DNA libraries for use on Illumina NGS platforms using a novel streamlined one-step enzymatic fragmentation, end-repair and A-addition protocol. We will discuss complete PCR-free solutions for whole genome and whole transcriptome sequencing from isolated single cells and low amounts of genomic DNA or RNA combined with a time-saving, one-tube library preparation protocol that does not require extra nucleic acids fragmentation and sample cleanup between steps, minimizing starting material loss and cross-contamination risk, thereby increasing the resolution of NGS data."

Duration: 45 minutes followed by Q&A session.

Schedule:

Monday, October 24, 2016 at 1:00 PM Eastern    Status: Available Reserve

Advanced NGS library prep for challenging samples

"Rapidly developing next-generation sequencing (NGS) technologies provide highly sensitive methods in discovering and characterizing the genetic information of a variety of samples. However, DNA samples are often limited in quantity, as well as compromised in quality. Such samples are not suitable for standard NGS library construction methods, which commonly require hundreds of nanograms of good-quality DNA. Examples of such challenging clinical samples include circulating DNA, laser capture microdissection (LCM) samples, formalin-fixed paraffin-embedded (FFPE) samples, ancient DNA and chromatin immunoprecipitation (ChIP) samples. In this webinar, we describe the measures that should be taken into consideration while sequencing such challenging samples. We will also present methods that can be used to optimize library construction to efficiently convert small amounts of DNA samples into sequencing libraries. "

Duration: 45 minutes followed by Q&A session.

Schedule:

Thursday, October 6, 2016 at 11:00 AM Eastern    Status: Available Reserve
Monday, October 31, 2016 at 1:00 PM Eastern    Status: Available Reserve

Introduction to microRNA

"microRNA plays a critical role in many biological processes such as differentiation and development, cell signaling, response to infection, and other challenges. Recent studies have shown overwhelming evidence that aberration in microRNA expression is causal or an indicator of many disease processes including cancer. Currently there is a race to find and develop microRNAs as biomarkers and therapeutics. To win the race, it is important to have a strong understanding of microRNA and the challenges of microRNA research. The webinar will cover the biology of microRNA, the key challenges associated with microRNA research, and the latest advances in microRNA research technology."

Duration: 45 minutes followed by Q&A session.

Schedule:

Tuesday, October 18, 2016 at 1:00 PM Eastern    Status: Available Reserve

Studying the microbiome: tools for microbial detection and host-response analysis

The research community has begun correlating the makeup of individual microbiomes with disorders and diseases such as autism, atherosclerosis, obesity and cancer. To accomplish this, researchers must first identify and characterize these microbial communities. This webinar will provide you with a complete overview of the microbiome, metagenomics and host-pathogen interactions. Experimental strategies to facilitate your microbiome research will be discussed. We will also present a variety of Sample to Insight workflows that integrate MO BIO’s nucleic acid isolation technology with QIAGEN’s microbial qPCR and NGS research tools.

Duration: 45 minutes followed by Q&A session.

Schedule:

Wednesday, September 28, 2016 at 1:00 PM Eastern    Status: Available Reserve
Monday, October 31, 2016 at 1:00 PM Eastern    Status: Available Reserve

CTC Detection and molecular characterisation – Challenges and Solutions

Circulating Tumor Cells (CTCs) have been extensively explored as circulating biomarkers in various cancers. Due to their rarity, heterogeneity and stem cell-like properties, detecting and profiling CTCs from blood samples is very challenging. In this webinar, Dr. Siegfried Hauch will introduce the well-known AdnaTests, which uses the Combination of Combinations Principle (COCP) to enable enriching and detecting CTCs in whole blood with high specificity and sensitivity, and how to overcome challenges in CTC enrichment and detection. The AdnaTests combine an immunomagnetic capturing method that increases purity, and is followed by molecular profiling of the captured CTCs. In addition, leukocyte contamination is another issue in CTCs detection and may lead to false positive results due to illegitimate expression of target genes or false interpretation. The AdnaWash is developed to reduce leukocyte contamination to such a level that whole gene panels can be analyzed while maintaining the required specificity and sensitivity.

Duration: 45 minutes followed by Q&A session.

Schedule:

Wednesday, October 19, 2016 at 9:30 AM Eastern    Status: Available Reserve

RNA-seq for biomarker discovery

"A biomarker is a characteristic that can be measured and evaluated as an indicator of a normal biological process, pathological process or response to therapy. Biomarkers can either be DNA- or RNA- based, or even both. Recently, transcriptional biomarkers, which are based on gene expression analysis, are gaining greater importance in clinical research. Transcriptional biomarkers provide information on the latest physiological status of the microenvironment and the response of cells to external or internal factors. The development of RNA sequencing, digital RNA sequencing and new bioinformatics tools enables us to identify, confirm and validate transcriptional (both mRNA and miRNA) biomarkers, , with a high level of accuracy. Limited sample amount, low-quality sample and large sample numbers are some of the common challenges faced by labs undertaking biomarker discovery. In addition, tight timelines and the lack of in-house expertise and facilities also hamper the use of the latest technologies. In this webinar, we will give you an overview of applying RNA sequencing strategies and techniques to biomarker discovery. The webinar will also discuss when to use whole transcriptome or mRNA sequencing and the application of bioinformatics solutions such as CLC Genomics Workbench and Ingenuity Variant Analysis in biomarker discovery. "

Duration: 45 minutes followed by Q&A session.

Schedule:

Tuesday, October 4, 2016 at 9:30 AM Eastern    Status: Available Reserve

Minimize biases in comparing metagenomics with metatranscriptomics: parallel isolation of DNA and RNA from stool sample

Duration: 45 minutes followed by Q&A session.

Schedule:

Monday, October 24, 2016 at 9:30 AM Eastern    Status: Available Reserve

Note: Viewers will be asked to register before viewing the previously recorded webinars.